Together, these studies indicate that APLNR blockade acts synergistically with VEGFA-blocking anti-angiogenesis by attenuating infiltrative GBM growth and decreasing resistance to current anti-angiogenic therapies. This evidence concerns the gene VEGFA and glioblastoma.